§ 58‑51‑58. Coverage for prostate‑specific antigen (PSA) tests.
(a) Every policy orcontract of accident and health insurance, and every preferred provider benefitplan under G.S. 58‑50‑56, that is issued, renewed, or amended on orafter January 1, 1994, shall provide coverage for prostate‑specificantigen (PSA) tests or equivalent tests for the presence of prostate cancer.The same deductibles, coinsurance, and other limitations as apply to similarservices covered under the policy, contract, or plan shall apply to coveragefor prostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer.
(b) As used in thissection, "prostate‑specific antigen (PSA) tests or equivalent testsfor the presence of prostate cancer" means serological tests fordetermining the presence of prostate cytoplasmic protein (PSA) and thegeneration of antibodies to it, as a novel marker for prostatic disease.
(c) Coverage forprostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer shall be provided when recommended by a physician. (1993,c. 269, s. 1; 1997‑519, s. 3.4.)
§ 58‑51‑58. Coverage for prostate‑specific antigen (PSA) tests.
(a) Every policy orcontract of accident and health insurance, and every preferred provider benefitplan under G.S. 58‑50‑56, that is issued, renewed, or amended on orafter January 1, 1994, shall provide coverage for prostate‑specificantigen (PSA) tests or equivalent tests for the presence of prostate cancer.The same deductibles, coinsurance, and other limitations as apply to similarservices covered under the policy, contract, or plan shall apply to coveragefor prostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer.
(b) As used in thissection, "prostate‑specific antigen (PSA) tests or equivalent testsfor the presence of prostate cancer" means serological tests fordetermining the presence of prostate cytoplasmic protein (PSA) and thegeneration of antibodies to it, as a novel marker for prostatic disease.
(c) Coverage forprostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer shall be provided when recommended by a physician. (1993,c. 269, s. 1; 1997‑519, s. 3.4.)
§ 58‑51‑58. Coverage for prostate‑specific antigen (PSA) tests.
(a) Every policy orcontract of accident and health insurance, and every preferred provider benefitplan under G.S. 58‑50‑56, that is issued, renewed, or amended on orafter January 1, 1994, shall provide coverage for prostate‑specificantigen (PSA) tests or equivalent tests for the presence of prostate cancer.The same deductibles, coinsurance, and other limitations as apply to similarservices covered under the policy, contract, or plan shall apply to coveragefor prostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer.
(b) As used in thissection, "prostate‑specific antigen (PSA) tests or equivalent testsfor the presence of prostate cancer" means serological tests fordetermining the presence of prostate cytoplasmic protein (PSA) and thegeneration of antibodies to it, as a novel marker for prostatic disease.
(c) Coverage forprostate‑specific antigen (PSA) tests or equivalent tests for thepresence of prostate cancer shall be provided when recommended by a physician. (1993,c. 269, s. 1; 1997‑519, s. 3.4.)
